Disclosures for "Real-world Healthcare Resource Utilization Following Initiation of Subcutaneous IgPro20 Among U.S. Patients With Chronic Inflammatory Demyelinating Polyneuropathy"
-
Mr. Kuatov has received personal compensation for serving as an employee of CSL Behring. Mr. Kuatov has stock in CSL Behring.
-
Mrs. Weng has received personal compensation for serving as an employee of CSL.
-
Mrs. Undreiner has received personal compensation for serving as an employee of CSL Behring. Mrs. Undreiner has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Vertex. Mrs. Undreiner has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Krystal Biotech. Mrs. Undreiner has stock in CSL Behring.
-
Mr. Chansakul has nothing to disclose.
-
Ms. Dabrowski has nothing to disclose.
-
Dr. Madsen has received personal compensation for serving as an employee of aetion. Dr. Madsen has stock in Aetion.